Article Details

Harbour BioMed Announces NMPA Approval of IND for Combination Therapy of Next Gen Anti ...

Retrieved on: 2021-02-26 02:15:00

Tags for this article:

Click the tags to see associated articles and topics

Harbour BioMed Announces NMPA Approval of IND for Combination Therapy of Next Gen Anti .... View article details on hiswai:

Excerpt

... both fully human monoclonal antibodies and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo